So that’s a no then. Particularly if/when the options are taken up. Dare to dream that the options get taken up! If Mesoblast gets knocked back with GVHD assays then your dream may come true! But, even then (if that does occur) big pharma may very well put a black mark against all MSCs until further notice. Time will tell. Hell of a gamble for mine.
CYP cutting away the dead weight. FF was slowing things down!
When is the CYP FDA P2 trial starting?
How much do you estimate Ross and the gang will get in KPIs (that are never disclosed and designed by the other BoDs) for a ‘successful’ CR for the FDA P2 for GVHD?
It’s got to be big, surely?
And I reckon it will far exceed the $12k that Ross contributed towards the CR out of his pocket.
I’m looking forward to Nov 2023. I feel there may be an early Christmas present for me (and Ross) that we are all going to enjoy discussing on HC.
CYP Price at posting:
13.5¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)